Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Disposition of vancomycin during hemofiltration.

G R Matzke, M B O'Connell, A J Collins

    Clinical Pharmacology and Therapeutics
    |October 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A case of distal limb arterial tortuosity and dilation: observations and potential clinical significance.

    Folia morphologica·2021
    Same author

    Insights Obtained by Culturing Saccharibacteria With Their Bacterial Hosts.

    Journal of dental research·2020
    Same author

    Application of two microsatellite sequences in wheat storage proteins as molecular markers.

    TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2013
    Same author

    Cardiovascular risk modification in participants with coronary disease screened by the Kidney Early Evaluation Program.

    Internal medicine journal·2011
    Same author

    Failed retrieval of an inferior vena cava filter during pregnancy because of filter tilt: report of two cases.

    Cardiovascular and interventional radiology·2008
    Same author

    Long-term outcomes in nondiabetic chronic kidney disease.

    Kidney international·2008

    Hemofiltration significantly alters vancomycin levels, drastically reducing its half-life (t 1/2) during treatment. Post-hemofiltration, vancomycin serum concentrations rebound, necessitating personalized dosing strategies for this antibiotic.

    Area of Science:

    • Pharmacokinetics and Pharmacodynamics
    • Nephrology and Critical Care Medicine
    • Infectious Disease Management

    Background:

    • Vancomycin is a critical antibiotic for treating serious Gram-positive infections.
    • Hemofiltration is used in critically ill patients to manage fluid and electrolyte balance.
    • The impact of hemofiltration on vancomycin disposition in patients is not well-established.

    Purpose of the Study:

    • To investigate the pharmacokinetic changes of vancomycin during hemofiltration.
    • To quantify vancomycin removal and clearance during hemofiltration.
    • To assess the post-hemofiltration rebound effect on vancomycin serum concentrations.

    Main Methods:

    • Five patients receiving intravenous vancomycin underwent pharmacokinetic profiling.

    Related Experiment Videos

  • Serum vancomycin concentrations were measured before, during, and after hemofiltration.
  • Vancomycin clearance and ultrafiltration rates were correlated.

    • Main Results:

    • Vancomycin's elimination half-life (t 1/2) decreased from 136.0 hours to 4.1 hours during hemofiltration.
    • Hemofiltration clearance of vancomycin was 152.6 ml/min, with approximately 400 mg removed.
    • A significant rebound in vancomycin serum concentration (52.4%) was observed post-hemofiltration.

    Conclusions:

    • Hemofiltration significantly impacts vancomycin disposition, increasing its clearance and reducing its half-life.
    • The observed rebound effect and interpatient variability necessitate individualized vancomycin dosing.
    • Adjusted vancomycin dosing regimens are crucial for patients undergoing hemofiltration to ensure therapeutic efficacy.